CD274 and neoplasm: Spranger et al. therefore identified, using mouse melanoma models, the mechanism by which tumor-intrinsic active β-catenin signaling led to T-cell exclusion and consequently to a resistance to anti-PD-L1/anti-CTLA-4 therapy [103].